INDIVUMED

Indivumed is a global oncology company and your resource for precision oncology. We are committed to shaping a future with individualized cancer therapy... As early as September 2001, Dr. Hartmut Juhl starts Indivumed GmbH. Shortly afterwards, Dr. Carsten Zornig, Dr. Peter Layer, and Frank Oertel join as cofounders. Despite - or perhaps because of - the name, which might be difficult to pronounce at first, investors are quickly found. With them and the first five employees, operations begin April 5, 2002. Soon after, Indivumed is awarded the Hamburger Gründerpreis for being the best start-up company in Hamburg... Indivumed Therapeutics is a biotech company focused on precision oncology. We create screening-ready novel target packages and partner with the pharmaceutical industry to develop precision cancer therapeutics.

Also known as: Indivumed GmbH, Indivumed Inc., Indivumed Services GmbH, Indivumed Therapeutics

Registration numbers: HRB 81965 (W)

VAT numbers: DE 221 189 542

Primary location: Hamburg Germany